Literature DB >> 15163501

Immunogenicity and protective efficacy of influenza vaccination.

Claude Hannoun1, Francoise Megas, James Piercy.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15163501     DOI： 10.1016/j.virusres.2004.02.025

Source DB:  PubMed          Journal:  Virus Res        ISSN： 0168-1702            Impact factor:   3.303


× No keyword cloud information.
  113 in total

1.  Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.

Authors:  Lisa M Christian; Chloe Beverly; Amanda M Mitchell; Erik Karlsson; Kyle Porter; Stacey Schultz-Cherry; Octavio Ramilo
Journal:  Vaccine       Date:  2017-08-01       Impact factor: 3.641

2.  Influenza update: a review of currently available vaccines.

Authors:  Lisa R Clayville
Journal:  P T       Date:  2011-10

3.  Vulnerability, distress, and immune response to vaccination in older adults.

Authors:  Suzanne C Segerstrom; Jaime K Hardy; Daniel R Evans; Richard N Greenberg
Journal:  Brain Behav Immun       Date:  2011-10-29       Impact factor: 7.217

4.  Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis.

Authors:  M-J Ma; X-X Wang; M-N Wu; X-J Wang; C-J Bao; H-J Zhang; Y Yang; K Xu; G-L Wang; M Zhao; W Cheng; W-J Chen; W-H Zhang; L-Q Fang; W J Liu; E-F Chen; W-C Cao
Journal:  Clin Microbiol Infect       Date:  2019-06-20       Impact factor: 8.067

5.  Zinc supplementation increases zinc status and thymopoiesis in aged mice.

Authors:  Carmen P Wong; Yang Song; Valerie D Elias; Kathy R Magnusson; Emily Ho
Journal:  J Nutr       Date:  2009-05-27       Impact factor: 4.798

6.  Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort.

Authors:  Marion Debin; Vittoria Colizza; Thierry Blanchon; Thomas Hanslik; Clement Turbelin; Alessandra Falchi
Journal:  Hum Vaccin Immunother       Date:  2013-12-16       Impact factor: 3.452

7.  Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial.

Authors:  Mary S Hayney; Christopher L Coe; Daniel Muller; Chidi N Obasi; Uba Backonja; Tola Ewers; Bruce Barrett
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

8.  Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Seunghyun Won; Rachel Lee; Tahaniyat Lalani; Anuradha Ganesan; Timothy Burgess; Brian K Agan
Journal:  Vaccine       Date:  2016-08-28       Impact factor: 3.641

Review 9.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  Immunogenicity and safety of an inactivated trivalent split influenza virus vaccine in young children with recurrent wheezing.

Authors:  E Young Bae; Ui Yoon Choi; Hyo Jin Kwon; Dae Chul Jeong; Jung Woo Rhim; Sang Hyuk Ma; Kyung Il Lee; Jin Han Kang
Journal:  Clin Vaccine Immunol       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.